Chronic Infections as Catalysts for Melanoma Aggressiveness: Insights into Tumour Microenvironment Modulation

Layza Sá Rocha1, Ana Cristina Jacobowski1, Eduarda Thiburcio Do Nascimento Reis1

  • 1Laboratory of Protein Purification and their Biological Functions, Federal University of Mato Grosso do Sul, 79070-900 Campo Grande-MS, Brazil.

Abstract

Insights

Chronic microbial infections worsen melanoma aggressiveness and resistance to treatment. Antimicrobial peptides (AMPs) show promise for controlling infection and improving melanoma therapy by modulating the tumor microenvironment.

Area of Science:

  • Oncology
  • Microbiology
  • Immunology

Background:

  • Cutaneous melanoma is an aggressive skin cancer with high metastatic potential.
  • Chronic microbial infections are increasingly recognized to influence melanoma progression and therapy resistance.
  • Pathogen interactions within the tumor microenvironment can promote immune evasion and epithelial-mesenchymal transition (EMT).

Purpose of the Study:

  • To investigate the role of chronic infections in melanoma aggressiveness.
  • To evaluate antimicrobial peptides (AMPs) as a potential therapeutic strategy for melanoma.

Main Methods:

  • A systematic review of peer-reviewed studies from 2020-2025 was conducted.
  • Databases searched included PubMed, Scopus, Web of Science, and Google Scholar.
  • Data synthesis focused on microbial species, antimicrobial resistance (AMR), AMP effectiveness, cytokines, immune pathways, and bioinformatics.

Main Results:

  • Specific pathogens (e.g., S. aureus, P. aeruginosa, C. tropicalis) exacerbate melanoma via inflammation and EMT.
  • Antimicrobial resistance (AMR) complicates treatment, especially in immunocompromised individuals.
  • Antimicrobial peptides (AMPs) demonstrate dual antimicrobial and immunomodulatory effects, with AI-driven design enhancing specificity and safety.

Conclusions:

  • Chronic microbial infections significantly impact melanoma aggressiveness and treatment resistance.
  • Antimicrobial peptides (AMPs) present a promising multifunctional approach for melanoma management.
  • Combining AMPs with immunotherapy may improve patient outcomes, warranting further clinical investigation.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.6K